UOTTAIMCU
KRTX

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,919
Closed -$5.88M – 56
2022
Q4 		$5.88M Sell
29,919
-19,869
-40% -$4.26M 2.21% 5
2022
Q3 		$11.2M Buy
+49,788
New +$10.1M 4.2% 3

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s KRTX Position: Q1 2023 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2023, closing a stake of 29,919 shares — an estimated $5.88M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in KRTX in Q3 2022 and held it in 2 quarters. The position peaked at $11.2M in Q3 2022. 246 funds tracked by Wall St. Rank hold KRTX as of Q1 2023.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 29,919 Karuna Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $5.88M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Karuna Therapeutics, Inc. Common Stock position peaked at $11.2M in Q3 2022.
  • 246 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2023.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2023, filed 22 May 2023.